New drugs, decades in the making, are providing relief for migraines

Nancy Baum Lipsitz remembers the night the pain began. She’d had a glass of white wine with a friend and went to bed with a terrible headache. The next day, she still felt horrible, the beginning of what she called a “rolling tide” of near constant ...

(Another) New Drug Approved For Migraine Prevention

Ajovy is first anti-CGRP treatment available at monthly and quarterly doses  The third new generation of CGRP antibody has been approved. It’s called Emgality (galcanezumab) which was just approved by the FDA on September 27th.   ·         Watch this interview preview with Professor Lars Edvinsson, the ...

Green Light – To Lilly’s Momoclonal Antibody To Migraine

Eli Lilly announces that the European Commission (EC) has approved the commercialization of galcanezumab (Emgality) as a prophylactic treatment of migraine in adults suffering from at least four days of migraine per month. Galcanezumab is a humanized monoclonal antibody that binds to the peptide related to the calcite ...